The clofibrate saga: a retrospective commentary

Br J Clin Pharmacol. 2012 Dec;74(6):907-10. doi: 10.1111/j.1365-2125.2012.04282.x.
No abstract available

MeSH terms

  • Anticholesteremic Agents / adverse effects
  • Anticholesteremic Agents / therapeutic use*
  • Clinical Trials as Topic
  • Clofibrate / adverse effects
  • Clofibrate / therapeutic use*
  • Coronary Disease / mortality
  • Coronary Disease / prevention & control*
  • Gallstones / chemically induced
  • Humans
  • Hypolipidemic Agents / adverse effects
  • Hypolipidemic Agents / therapeutic use*
  • Male

Substances

  • Anticholesteremic Agents
  • Hypolipidemic Agents
  • Clofibrate